BIO Asia–Taiwan 2023 亞洲生技大會

BIO Asia–Taiwan 2023 亞洲生技大會


Chi-Huey Wong

Session 7 - Future Pandemic Preparedness

Date:28 July (Thursday)
Time:  10:40 – 12:00 (GMT+8)

Chi-Huey Wong

Scripps Family Chair Professor of Chemistry
​The Scripps Research Institute

Professor Wong received his B.S. (1970) and M.S. (1977) degrees (with KT Wang) from National Taiwan University, and Ph.D. (1982) in Chemistry (with George M. Whitesides) from Massachusetts Institute of Technology. He then worked at Harvard University as a postdoctoral fellow (with George M. Whitesides) for another year, and became a faculty member at Texas A&M University (1983) where he was promoted to full professor in 1987. He then moved to The Scripps Research Institute in 1989 as Professor and Ernest W. Hahn Chair in Chemistry. From 2006 to 2016, he served as President of Academia Sinica in Taiwan. He is currently the Scripps Family Chair Professor of Chemistry at The Scripps Research Institute and holds a joint appointment as Distinguished Professor at the Genomics Research Center, Academia Sinica.  

Professor Wong received numerous honors for recognition of his accomplishments, including, for example, the Presidential Young Investigator Award in Chemistry USA (1986), the Roy Whistler Award of the International Carbohydrate Organization (1994), the ACS Claude S. Hudson Award in Carbohydrate Chemistry (1999), the International Enzyme Engineering Award (1999), the US Presidential Green Chemistry Challenge Award (2000), The ACS Award for Creative Work in Synthetic Organic Chemistry (2005), Humboldt Research Award for Senior Scientists (2006), the ACS Arthur C. Cope Medal (2012), the Wolf Prize in Chemistry (2014), and the Robert Robinson Award of the Royal Society of Chemistry, UK (2015). 

He is a member of Academia Sinica (1994), the American Academy of Arts and Sciences (1996), the US National Academy of Sciences (2002) and the US National Academy of Inventors (2014). He served as Chairman of the Executive Board of Editors of the Tetrahedron Publications (2006-2008), Head of the Frontier Research Program on Glycotechnology at RIKEN in Japan (1991–1999), and a board member of the US National Research Council on Chemical Sciences and Technology (2000–2003). In addition, he has received many honorary doctor degrees, given numerous plenary and named lectures, and served as a science advisor to many organizations, including the Max-Planck Institute (2000-2008) and RIKEN (2010-16), and as the Chief Science Advisor to Taiwan Government (2006-2015).His research interests are in the field of chemical biology and synthetic chemistry, with particular focus on the development of new methods and tools for the synthesis and study of complex carbohydrates and glycoproteins, and development of new medicines, universal vaccines and homogeneous antibodies associated with carbohydrate recognition. He has published over 750 papers and received more than 120 patents and is a highly cited scientist with an h-index of 153.

Speech title & Synopsis

Development of Universal COVID Vaccine